Neglected Tropical Diseases

Medicine & Life Sciences

1. Ethiopia 100%
2. Visceral Leishmaniasis 85%
3. Guinea 47%
4. HIV 44%
5. Disease Outbreaks 35%
6. Ebola Hemorrhagic Fever 34%
7. Cambodia 32%
8. Cutaneous Leishmaniasis 26%
9. Sierra Leone 19%
10. Coinfection 18%
11. Belgium 16%
12. Zika Virus 15%
13. Leishmaniasis 15%
14. Therapeutics 15%
15. Hepacivirus 14%
16. Routine Diagnostic Tests 14%
17. Tuberculosis 14%
18. HIV Infections 13%
19. Malaria 13%
20. Myanmar 12%
21. Chikungunya virus 12%
22. Retrospective Studies 12%
23. Democratic Republic of the Congo 12%
24. Polymerase Chain Reaction 12%
25. Hepatitis C 12%
26. Cohort Studies 11%
27. miltefosine 11%
28. Leishmania 11%
29. Recurrence 11%
30. Eastern Africa 10%
31. Schistosomiasis 10%
32. Clinical Trials 10%
33. Microscopy 10%
34. Genotype 10%
35. Pentamidine 10%
36. Zika Virus Infection 10%
37. Cross-Sectional Studies 9%
38. Fever 9%
39. Elephantiasis 9%
40. Neglected Diseases 8%
41. Africa South of the Sahara 8%
42. liposomal amphotericin B 8%
43. Antibodies 8%
44. Mortality 8%
45. Paromomycin 8%
46. Antimony Sodium Gluconate 8%
47. Referral and Consultation 7%
48. Antigens 7%
49. Leprosy 7%
50. Child 7%
51. Health Facilities 7%
52. Aspirations (Psychology) 7%
53. Vaccines 7%
54. Treatment Failure 6%
55. Virus Diseases 6%
56. Survivors 6%
57. Aruba 6%
58. Infection 6%
59. Skin 6%
60. Enzyme-Linked Immunosorbent Assay 6%
61. Confidence Intervals 6%
62. CD4 Lymphocyte Count 6%
63. Monkeypox virus 6%
64. Epidemics 6%
65. Sensitivity and Specificity 6%
66. Safety 6%
67. picaridin 6%
68. Monkeypox 6%
69. Anti-Bacterial Agents 6%
70. Schistosoma 5%
71. Pandemics 5%
72. Delivery of Health Care 5%
73. Tropical Medicine 5%
74. Evaluation Studies 5%
75. 2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole 5%
76. MK-5172 5%
77. Guidelines 5%
78. Mass Drug Administration 5%
79. Insect Repellents 5%
80. Sudan 5%
81. Emergencies 5%